There have been three presentations of the phase III TOPGEAR trial in 2019. TOPGEAR, led by Prof Trevor Leong, is a randomised trials investigating neoadjuvant strategies for gastric cancer.
“The trial is in the final stages of recruitment and with over 500 patients recruited, it is already the largest trial evaluating preoperative chemoradiation for gastric cancer,” says Prof Leong. “TOPGEAR continues to generate considerable interest at international meetings and the results are eagerly awaited by clinicians worldwide. Recent international presentations have focused on the advantages of delivering adjuvant therapy preoperatively, and reporting safety data associated with the use of newer chemotherapy regimens.”
The presentations were held at ASCO GI in January and the International Gastric Cancer Congress (IGCC) in May.